Listeria Monocytogenes

• USES: • For the temporary relief of symptoms including: • mucus congestion • stomach discomfort • fever • headache • cough • joint discomfort • occasional diarrhea • bladder discomfort These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.ICD-10: R05.9, R51.9

DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.

Recent PubMed references pinned to Listeria Monocytogenes as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Integrative computational analysis of plant-derived flavonoids as inhibitors of Listeriolysin O and Internalin A in Listeria monocytogenes.
  PloS one · 2026 · Sourav SH, Siddiquee NH, Tabassum R, et al.
  PMID 42263139DOI 10.1371/journal.pone.0351129
• Avoidance of MAIT cells is an essential determinant of Listeria monocytogenes pathogenesis.
  Proceedings of the National Academy of Sciences of the United States of America · 2026 · Rivera-Lugo R, Garcia Castillo J, Lobanovska M, et al.
  PMID 42258727DOI 10.1073/pnas.2601925123
• Host methylglyoxal activates the Listeria virulence program, allowing bacteria to evade inflammatory phagocytes by cell-to-cell spread.
  Proceedings of the National Academy of Sciences of the United States of America · 2026 · Anaya-Sanchez A, Ragunathan PT, Hung A, et al.
  PMID 42234520DOI 10.1073/pnas.2534912123
• Fluorescent covalent organic framework and multivalent aptamer-driven magnetic nanoplatform for sensitive detection of foodborne pathogens.
  Mikrochimica acta · 2026 · Huang S, Shen H, Ding L, et al.
  PMID 42217085DOI 10.1007/s00604-026-08157-6
• Genomic and transcriptomic analysis of biofilm formation in foodborne Listeria monocytogenes isolates under combined environmental stress.
  Food microbiology · 2026 · Liu Z, Gao X, Wang Y, et al.
  PMID 42215228DOI 10.1016/j.fm.2026.105148
• Survival and genomic adaptation of Listeria monocytogenes in long-term culture.
  Food microbiology · 2026 · Benetti S, Carraro L, Mohammadpour H, et al.
  PMID 42215227DOI 10.1016/j.fm.2026.105147
• Functional impact of dietary chitin upon Listeria monocytogenes pathogenesis.
  Food microbiology · 2026 · Cazzaniga M, Shen P, Flegar D, et al.
  PMID 42215197DOI 10.1016/j.fm.2026.105117
• Surface growth diversity between Listeria monocytogenes strains resulting from oxygen and pH interactions.
  Food microbiology · 2026 · Van Reepingen A, Santi F, Wijns R, et al.
  PMID 42215195DOI 10.1016/j.fm.2026.105115

The 10 most recently updated of 22 ClinicalTrials.gov registrations naming Listeria Monocytogenes as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
  Recruiting · Phase 1 · Interventional · 18 enrolled · Thomas Jefferson University
  NCT07417488updated 2026-05-08
• Neurological Consequences of Perinatal Listeriosis Infection
  Completed · Interventional · 53 enrolled · Assistance Publique - Hôpitaux de Paris
  NCT02580812updated 2025-09-11
• An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung
  Terminated · Phase 1 · Phase 2 · Interventional · 12 enrolled · Janssen Research & Development, LLC
  NCT03371381updated 2025-02-04
• Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer
  Terminated · Phase 1 · Interventional · 18 enrolled · Janssen Research & Development, LLC
  NCT02592967updated 2025-02-03
• Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer
  Completed · Phase 1 · Interventional · 26 enrolled · Janssen Research & Development, LLC
  NCT02625857updated 2025-02-03
• Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer
  Completed · Phase 1 · Phase 2 · Interventional · 24 enrolled · Advaxis, Inc.
  NCT03847519updated 2024-06-04
• A Study of Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus Positive (HPV+), NSCLC Following First-Line Induction Chemotherapy
  Withdrawn · Phase 2 · Interventional · 0 enrolled · Advaxis, Inc.
  NCT02531854updated 2023-12-19
• RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)
  Unknown · Observational · 12 enrolled · Peihua Lu
  NCT05930301updated 2023-07-05
• ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal Cancer
  Completed · Phase 2 · Interventional · 15 enrolled · Andrew Sikora
  NCT02002182updated 2022-09-22
• Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer
  Terminated · Phase 1 · Interventional · 28 enrolled · Aduro Biotech, Inc.
  NCT03189030updated 2020-10-01

Frequently asked questions

What is Listeria Monocytogenes used for?

According to FDA labeling, Listeria Monocytogenes carries indications including: USES: • For the temporary relief of symptoms including: • mucus congestion • stomach discomfort • fever • headache • cough • joint discomfort • occasional diarrhea • bladder discomfort These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.